Table of Contents Author Guidelines Submit a Manuscript
Neural Plasticity
Volume 2012, Article ID 171639, 14 pages
http://dx.doi.org/10.1155/2012/171639
Review Article

Molecular and Cellular Alterations in Down Syndrome: Toward the Identification of Targets for Therapeutics

Unité de Biologie Fonctionnelle et Adaptative (BFA), Sorbonne Paris Cité, Universite Paris Diderot, EAC4413 CNRS, 75205 Paris Cedex 13, France

Received 3 February 2012; Revised 18 April 2012; Accepted 19 April 2012

Academic Editor: Hansen Wang

Copyright © 2012 Nicole Créau. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [16 citations]

The following is the list of published articles that have cited the current article.

  • Jonathan D. Picker, “New Innovations: Therapeutic Opportunities for Intellectual Disabilities,” Annals of Neurology, vol. 74, no. 3, pp. 382–390, 2013. View at Publisher · View at Google Scholar
  • Mark J. Millan, “An epigenetic framework for neurodevelopmental disorders: From pathogenesis to potential therapy,” Neuropharmacology, vol. 68, pp. 2–82, 2013. View at Publisher · View at Google Scholar
  • Patrizia Bianchi, Simone Bettini, Sandra Guidi, Elisabetta Ciani, Stefania Trazzi, Fiorenza Stagni, Elena Ragazzi, Valeria Franceschini, and Renata Bartesaghi, “Age-related impairment of olfactory bulb neurogenesis in the Ts65Dn mouse model of Down syndrome,” Experimental Neurology, 2013. View at Publisher · View at Google Scholar
  • Mouton-Liger François, Ignasi Sahún, Thibault Collin, Patricia Lopes Pereira, Debora Masini, Sophie Thomas, Evelyne Paly, Sabrina Luilier, Sandra Même, Quentin Jouhault, Soumia Bennaï, Jean-Claude Beloeil, Jean-Charles Bizot, Yann Hérault, Mara Dierssen, and Nicole Créau, “Developmental molecular and functional cerebellar alterations induced by PCP4/PEP19 overexpression: Implications for Down syndrome,” Neurobiology of Disease, 2013. View at Publisher · View at Google Scholar
  • Farrah Rajabi, and Jonathan D. Picker, “New Innovations: Therapies for Genetic Conditions,” Current Genetic Medicine Reports, 2014. View at Publisher · View at Google Scholar
  • Benoit Souchet, Fayçal Guedj, Ignasi Sahún, Arnaud Duchon, Fabrice Daubigney, Anne Badel, Yuchio Yanagawa, Maria Jose Barallobre, Mara Dierssen, Eugene Yu, Yann Herault, Mariona Arbones, Nathalie Janel, Nicole Créau, and Jean Maurice Delabar, “Excitation/inhibition balance and learning are modified by Dyrk1a gene dosage,” Neurobiology of Disease, 2014. View at Publisher · View at Google Scholar
  • Michael Telias, and Dalit Ben-Yosef, “Modeling Neurodevelopmental Disorders Using Human Pluripotent Stem Cells,” Stem Cell Reviews and Reports, 2014. View at Publisher · View at Google Scholar
  • H. Craig Heller, Ahmad Salehi, Bayarsaikhan Chuluun, D. Devsmita Das, Bill Lin, Sarah Moghadam, Craig C. Garner, and Damien Colas, “Nest building is impaired in the Ts65Dn mouse model of Down syndrome and rescued by blocking 5HT2a receptors,” Neurobiology of Learning and Memory, 2014. View at Publisher · View at Google Scholar
  • María Luz Montesinos, “Pharmacological intervention for down syndrome cognitive deficits: Emerging drug targets,” CNS and Neurological Disorders - Drug Targets, vol. 13, no. 1, pp. 6–7, 2014. View at Publisher · View at Google Scholar
  • S.L. Perlman, “Down's Syndrome,” Encyclopedia of the Neurological Sciences, pp. 1026–1028, 2014. View at Publisher · View at Google Scholar
  • Shani Stern, Menahem Segal, and Elisha Moses, “Involvement of Potassium and Cation Channels in Hippocampal Abnormalities of Embryonic Ts65Dn and Tc1 Trisomic Mice,” EBioMedicine, vol. 2, no. 9, pp. 1048–1062, 2015. View at Publisher · View at Google Scholar
  • Andrea Giacomini, Fiorenza Stagni, Stefania Trazzi, Sandra Guidi, Marco Emili, Elizabeth Brigham, Elisabetta Ciani, and Renata Bartesaghi, “Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome,” Neurobiology of Disease, vol. 82, pp. 385–396, 2015. View at Publisher · View at Google Scholar
  • Nicole Créau, Eva Cabet, Fabrice Daubigney, Benoit Souchet, Soumia Bennaï, and Jean Delabar, “Specific age-related molecular alterations in the cerebellum of Down syndrome mouse models,” Brain Research, 2016. View at Publisher · View at Google Scholar
  • Jacqueline London, Claude Rouch, Linh Chi Bui, Elodie Assayag, Benoit Souchet, Fabrice Daubigney, Hind Medjaoui, Serge Luquet, Christophe Magnan, Jean Maurice Delabar, Julien Dairou, and Nathalie Janel, “Overexpression of the DYRK1A Gene (Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A) Induces Alterations of the Serotoninergic and Dopaminergic Processing in Murine Brain Tissues,” Molecular Neurobiology, 2017. View at Publisher · View at Google Scholar
  • Damien Colas, Bayarsaikhan Chuluun, Craig C. Garner, and H. Craig Heller, “Short-term treatment with flumazenil restores long-term object memory in a mouse model of Down syndrome,” Neurobiology of Learning and Memory, vol. 140, pp. 11–16, 2017. View at Publisher · View at Google Scholar
  • Rosa Anna Vacca, Sweta Bawari, Daniela Valenti, Devesh Tewari, Seyed Fazel Nabavi, Samira Shirooie, Archana N. Sah, Mariateresa Volpicella, Nady Braidy, and Seyed Mohammad Nabavi, “Down syndrome: neurobiological alterations and therapeutic targets,” Neuroscience & Biobehavioral Reviews, 2019. View at Publisher · View at Google Scholar